• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 15, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Simulation Study Reveals Bias in Self-Controlled Drug Safety Designs

by
November 9, 2026
in Health
Reading Time: 2 mins read
0
Simulation Study Reveals Bias in Self-Controlled Drug Safety Designs

Simulation Study Reveals Bias in Self-Controlled Drug Safety Designs

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A simulation study published in BMC Medical Research Methodology has identified significant biases in several self-controlled designs used for drug safety assessments. The research, conducted by Masatomo Omiya and Tosiya Sato, evaluates how exposure time trends affect the accuracy of estimators when using electronic healthcare databases. The study focuses on the challenge of assessing associations between drugs and adverse drug reactions, where information on confounding factors is often incomplete. Self-controlled designs are commonly employed to mitigate confounding by time-invariant factors, but the authors demonstrate that changing drug use frequencies over time can distort the resulting estimates.

The primary objective of the simulation was to evaluate the performance of five specific self-controlled designs under various exposure time trends and scenarios. The designs examined were the case-crossover, case-time-control, case-case-time-control, symmetric bidirectional case-crossover, and self-controlled case series.

The simulation incorporated four distinct patterns of exposure time trends to test the resilience of the estimators. These patterns included a constant exposure rate, a linear increase, a cosine function-pattern temporal change, and a mountain-pattern temporal change.

Three specific scenarios were investigated to understand the broader context of these biases. The first scenario examined the impact of exposure time trends alone on the estimators. The second scenario considered situations where adverse drug reaction events restrict the length of the observation periods. The third scenario explored cases where the occurrence of an adverse drug reaction influences subsequent exposures.

The results indicated that the case-crossover design exhibited the most pronounced positive bias in estimates. This bias was particularly evident when the exposure time trend demonstrated a linear increase of more than 20% per year or when a mountain-pattern temporal change was present. In contrast, the symmetric bidirectional case-crossover design showed a negative bias specifically under the cosine function-pattern temporal change.

Other designs, including case-time-control, case-case-time-control, and self-controlled case series, showed little bias from exposure time trends. However, the study noted that case-time-control and case-case-time-control were less precise than the other self-controlled designs.

The study also found that when adverse drug reaction occurrence affected the observation period or subsequent exposure, the estimation performance of symmetric bidirectional case-crossover and self-controlled case series was substantially affected.

The authors conclude that design selection for drug safety assessments should first consider whether adverse drug reaction occurrence may affect the observation period or subsequent exposure. Following this initial assessment, researchers should consider the anticipated exposure time trends and the available data structure.

Subject of Research: Impact of exposure time trends on self-controlled design estimators in drug safety simulation studies

Article Title: Impact of exposure time trends on estimators of self-controlled designs in drug safety assessment using electronic healthcare databases: a simulation study

Article References: Omiya, M., & Sato, T. (2026). Impact of exposure time trends on estimators of self-controlled designs in drug safety assessment using electronic healthcare databases: a simulation study. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-026-03037-2

Image Credits: AI Generated

DOI: 10.1186/s12874-026-03037-2

Keywords: drug safety, simulation study, self-controlled designs, case-crossover, exposure time trends, pharmacoepidemiology, electronic healthcare databases, statistical bias, adverse drug reactions, Impact, exposure, time

News Source: Louis Brooks. (November 9, 2026). Simulation Study Reveals Bias in Self-Controlled Drug Safety Designs. Scienmag.

Tags: adverse drug reactionscase-crossoverdrug safetyelectronic healthcare databasesexposureexposure time trendsimpactpharmacoepidemiologyself-controlled designssimulation studystatistical biastime
Share12Tweet7Share2ShareShareShare1

Related Posts

Severe Delusion-Dominant Psychosis Marks Atypical Parkinson's Disease Case Report

Severe Delusion-Dominant Psychosis Marks Atypical Parkinson’s Disease Case Report

November 15, 2026
Repeated Heat Waves Linked to Childhood Adversity and Distress in Nepal

Repeated Heat Waves Linked to Childhood Adversity and Distress in Nepal

November 15, 2026

Distinct Genomic Landscapes Distinguish Survival Outcomes in Systemic Anaplastic Large Cell Lymphomas

November 15, 2026

Blood Cancer Antibody–Drug Conjugates Require Balanced Target Biology and Linker–Payload Pharmacology

November 15, 2026

POPULAR NEWS

  • Distinct Genomic Landscapes Distinguish Survival Outcomes in Systemic Anaplastic Large Cell Lymphomas

    Distinct Genomic Landscapes Distinguish Survival Outcomes in Systemic Anaplastic Large Cell Lymphomas

    29 shares
    Share 12 Tweet 7
  • Blood Cancer Antibody–Drug Conjugates Require Balanced Target Biology and Linker–Payload Pharmacology

    29 shares
    Share 12 Tweet 7
  • Telomeric C-Circles Emerge as Functional and Actionable Biomarkers in ALT-Driven Cancers

    29 shares
    Share 12 Tweet 7
  • Review Outlines How Neural and Endocrine Circuits Govern CD8 T Cell Fate

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Severe Delusion-Dominant Psychosis Marks Atypical Parkinson’s Disease Case Report

Repeated Heat Waves Linked to Childhood Adversity and Distress in Nepal

Distinct Genomic Landscapes Distinguish Survival Outcomes in Systemic Anaplastic Large Cell Lymphomas

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.